IGF-2 is a mediator of prolactin-induced morphogenesis in the breast

被引：141

作者：

Brisken, C ^{[1
]}

Ayyannan, A

Nguyen, C

Heineman, A

机构：

[1] Harvard Univ, Sch Med, Dept Surg Oncol, Boston, MA 02114 USA

[2] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA

[3] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA

[4] Massachusetts Gen Hosp, Charlestown, MA 02129 USA

[5] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA

[6] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA

来源：

DEVELOPMENTAL CELL | 2002年 / 3卷 / 06期

关键词：

D O I：

10.1016/S1534-5807(02)00365-9

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The mechanisms by which prolactin controls proliferation of mammary epithelial cells (MECs) and morphogenesis of the breast epithelium are poorly understood. We show that cyclin D1(-/-) MECs fail to proliferate in response to prolactin and identify IGF-2 as a downstream target of prolactin signaling that lies upstream of cyclin D1 transcription. Ectopic IGF-2 expression restores alveologenesis in prolactin receptor(-/-) epithelium. Alveologenesis is retarded in IGF-2-deficient MECs. IGF-2 and prolactin receptor mRNAs colocalize in the mammary epithelium. Prolactin induces IGF-2 mRNA and IGF-2 induces cyclin D1 protein in primary MECs. Thus, IGF-2 is a mediator of prolactin-induced alveologenesis; prolactin, IGF-2, and cyclin D1, all of which are overexpressed in breast cancers, are components of a developmental pathway in the mammary gland.

引用

页码：877 / 887

页数：11

共 50 条

[1] The IGF-I receptor and cancer [J].

Baserga, R ;

Resnicoff, M ;

Dews, M .

ENDOCRINE, 1997, 7 (01) :99-102

[2] Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration [J].

Binart, N ;

Helloco, C ;

Ormandy, CJ ;

Barra, J ;

Clément-Lacroix, P ;

Baran, N ;

Kelly, PA .

ENDOCRINOLOGY, 2000, 141 (07) :2691-2697

[3] Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice [J].

Bole-Feysot, C ;

Goffin, V ;

Edery, M ;

Binart, N ;

Kelly, PA .

ENDOCRINE REVIEWS, 1998, 19 (03) :225-268

[4] Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds [J].

Bonnette, SG ;

Hadsell, DL .

ENDOCRINOLOGY, 2001, 142 (11) :4937-4945

[5] A paracrine role for the epithelial progesterone receptor in mammary gland development [J].

Brisken, C ;

Park, S ;

Vass, T ;

Lydon, JP ;

O'Malley, BW ;

Weinberg, RA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5076-5081

[6] Prolactin controls mammary gland development via direct and indirect mechanisms [J].

Brisken, C ;

Kaur, S ;

Chavarria, TE ;

Binart, N ;

Sutherland, RL ;

Weinberg, RA ;

Kelly, PA ;

Ormandy, CJ .

DEVELOPMENTAL BIOLOGY, 1999, 210 (01) :96-106

[7]

Brisken C, 2000, GENE DEV, V14, P650

[8] PRL activates the cyclin D1 promoter via the Jak2/Stat pathway [J].

Brockman, JL ;

Schroeder, MD ;

Schuler, LA .

MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) :774-784

[9] IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development [J].

Cao, YX ;

Bonizzi, G ;

Seagroves, TN ;

Greten, FR ;

Johnson, R ;

Schmidt, EV ;

Karin, M .

CELL, 2001, 107 (06) :763-775

[10]

CLEVENGER CV, 1995, AM J PATHOL, V146, P695

← 1 2 3 4 5 →